CARVOLIX SA (CVX.PA) Stock Price & Overview
EPA:CVX • FR0013333077
Current stock price
The current stock price of CVX.PA is 3.03 EUR. Today CVX.PA is down by -6.19%. In the past month the price decreased by -15.83%.
CVX.PA Key Statistics
- Market Cap
- 179.497M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.38
- Dividend Yield
- N/A
CVX.PA Stock Performance
CVX.PA Stock Chart
CVX.PA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to CVX.PA.
CVX.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CVX.PA. CVX.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
CVX.PA Earnings
CVX.PA Forecast & Estimates
8 analysts have analysed CVX.PA and the average price target is 3.91 EUR. This implies a price increase of 29.04% is expected in the next year compared to the current price of 3.03.
CVX.PA Groups
Sector & Classification
CVX.PA Financial Highlights
Over the last trailing twelve months CVX.PA reported a non-GAAP Earnings per Share(EPS) of -0.38. The EPS increased by 29.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -24.64% | ||
| ROE | -69.84% | ||
| Debt/Equity | 1 |
CVX.PA Ownership
CVX.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ESL | ESSILORLUXOTTICA | 26.66 | 95.067B | ||
| EL | ESSILORLUXOTTICA | 26.59 | 94.835B | ||
| 1EL | ESSILORLUXOTTICA | 25.45 | 94.789B | ||
| GBT | GUERBET | N/A | 111.738M | ||
| ALCJ | CROSSJECT | 5.42 | 103.267M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 49.104M | ||
| IVN | IVISION TECH SPA | N/A | 13.803M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About CVX.PA
Company Profile
Affluent Medical SA provides treatments for serious and widespread diseases. The company is headquartered in Aix-En-Provence, Paca and currently employs 76 full-time employees. The company went IPO on 2021-06-14. The company designs minimally invasive prostheses at mimicking human anatomy and restoring native physiology for critical functions in cardiovascular and urological therapies. The company provides several products such as Kalios, Epygon, Artus. The company helps in treating heart disease and urinary incontinence. The firm provides transcatheter and flow control technologies, such as mimicry of anatomy and restoration of physiology minimally invasive implant procedures, optimized and biocompatible components.
Company Info
IPO: 2021-06-14
CARVOLIX SA
320 avenue Archimede, Les pleiades III Batiment B
Aix-en-Provence PACA FR
Employees: 76
Phone: 33442951220
CARVOLIX SA / CVX.PA FAQ
What does CVX do?
Affluent Medical SA provides treatments for serious and widespread diseases. The company is headquartered in Aix-En-Provence, Paca and currently employs 76 full-time employees. The company went IPO on 2021-06-14. The company designs minimally invasive prostheses at mimicking human anatomy and restoring native physiology for critical functions in cardiovascular and urological therapies. The company provides several products such as Kalios, Epygon, Artus. The company helps in treating heart disease and urinary incontinence. The firm provides transcatheter and flow control technologies, such as mimicry of anatomy and restoration of physiology minimally invasive implant procedures, optimized and biocompatible components.
What is the current price of CVX stock?
The current stock price of CVX.PA is 3.03 EUR. The price decreased by -6.19% in the last trading session.
Does CVX stock pay dividends?
CVX.PA does not pay a dividend.
What is the ChartMill technical and fundamental rating of CVX stock?
CVX.PA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the market expecting CVX stock to perform?
8 analysts have analysed CVX.PA and the average price target is 3.91 EUR. This implies a price increase of 29.04% is expected in the next year compared to the current price of 3.03.
Would investing in CARVOLIX SA be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CVX.PA.